Glioblastoma (GBM), the most lethal primary brain malignancy, has long frustrated oncologists and researchers. Characterized by aggressive...
Layla Zulfa
Amsterdam, Netherlands – In a landmark development poised to redefine the landscape of metabolic disease management, Fractyl...
In a remarkable convergence of reproductive biology and ophthalmological innovation, researchers have pioneered a non-invasive treatment for...
In the meticulous world of oncological research, where the difference between a successful breakthrough and a failed...
A recent study published in the medical journal Cancers (2026) has introduced a critical shift in how...
The development of therapies for ultra-rare diseases—conditions affecting fewer than 1,000, and sometimes fewer than 10, individuals—represents...
By Investigative Health Desk April 16, 2026 The journey through a cancer diagnosis is rarely a straight...
Introduction: A Silent Crisis in Plain Sight In May 2023, U.S. Surgeon General Dr. Vivek Murthy issued...
By Editorial Staff As the medical community continues to push the boundaries of oncology, the quest for...
As the first quarter of 2026 draws to a close, the METAvivor advocacy team is intensifying its...
